Cell biology of the movement of breast cancer cells: Intracellular signalling and the actin cytoskeleton

Cancer Letters

Volumn 284, Issue 2, 2009, Pages 122-130

  Jiang, Ping ^a   Enomoto, Atsushi ^a,b   Takahashi, Masahide ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

Actin cytoskeleton; Akt kinase; Breast cancer; Cell motility; Endocytosis; Rho GTPases

Indexed keywords

ACTIN; CHEMOKINE; CYTOKINE; GROWTH FACTOR; INTEGRIN; PROTEIN KINASE B; RHO GUANINE NUCLEOTIDE BINDING PROTEIN;

BREAST CANCER; CANCER CELL; CELL INVASION; CELL MOTILITY; CHEMOTAXIS; CYTOLOGY; CYTOSKELETON; ENDOCYTOSIS; EXTRACELLULAR MATRIX; HUMAN; METASTASIS; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; SHORT SURVEY; SIGNAL TRANSDUCTION; TARGET CELL;

EID: 69549096143     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.02.034     Document Type: Review

References (75)

1. Ferlay J., Autier P., Boniol M., Heanue M., Colombet M., and Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann. Oncol. 18 (2007) 581-592
2. Pollard T.D., and Borisy G.G. Cellular motility driven by assembly and disassembly of actin filaments. Cell 112 (2003) 453-465
3. Mitchison T.J., and Cramer L.P. Actin-based cell motility and cell locomotion. Cell 84 (1996) 371-379
4. Allingham J.S., Klenchin V.A., and Rayment I. Actin-targeting natural products: structures, properties and mechanisms of action. Cell. Mol. Life Sci. 63 (2006) 2119-2134
5. Chhabra E.S., and Higgs H.N. The many faces of act, matching assembly factors with cellular structures. Nat. Cell. Biol. 9 (2007) 1110-1121
6. Friedl P., and Wolf K. Tumor-cell invasion and migration: diversity and escape mechanisms. Nat. Rev. Cancer 3 (2003) 362-374
7. Broussard J.A., Webb D.J., and Kaverina I. Asymmetric focal adhesion disassembly in motile cells. Curr. Opin. Cell. Biol. 20 (2008) 85-90
8. Schmidt A., and Hall M.N. Signaling to the actin cytoskeleton. Ann. Rev. Cell. Dev. Biol. 14 (1998) 305-338
9. Etienne-Manneville S., and Hall A. Rho GTPases in cell biology. Nature 420 (2002) 629-635
10. Hall A. Rho GTPases and the actin cytoskeleton. Science 279 (1998) 509-514
11. Heasman S.J., and Ridley A.J. Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat. Rev. Mol. Cell. Biol. 9 (2008) 690-701
12. Lin M., and van Golen K.L. Rho-regulatory proteins in breast cancer cell motility and invasion. Breast Cancer Res. Tr. 84 (2004) 49-60
13. Burbelo P., Wellstein A., and Pestell R.G. Altered Rho GTPase signaling pathways in breast cancer cells. Breast Cancer Res. Tr. 84 (2004) 43-48
14. Fritz G., Brachetti C., Bahlmann F., Schmidt M., and Kaina B. Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters. Br. J. Cancer 87 (2002) 635-644
15. Fritz G., Just I., and Kaina B. Rho GTPases are over-expressed in human tumors. Int. J. Cancer 81 (1999) 682-687
16. Bellizzi A., Mangia A., Chiriatti A., Petroni S., Quaranta M., Schittulli F., Malfettone A., Cardone R.A., Paradiso A., and Reshkin S.J. RhoA protein expression in primary breast cancers and matched lymphocytes is associated with progression of the disease. Int. J. Mol. Med. 22 (2008) 25-31
17. Bouzahzah B., Albanese C., Ahmed F., Pixley F., Lisanti M.P., Segall J.D., Condeelis J., Joyce D., Minden A., Der C.J., Chan A., Symons M., and Pestell R.G. Rho family GTPases regulate mammary epithelium cell growth and metastasis through distinguishable pathways. Mol. Med. 7 (2001) 816-830
18. Riento K., and Ridley A.J. Rocks: multifunctional kinases in cell behaviour. Nat. Rev. Mol. Cell Biol. 4 (2003) 446-456
19. Zaoui K., Honoré S., Isnardon D., Braguer D., and Badache A. Memo-RhoA-mDia1 signaling controls microtubules, the actin network, and adhesion site formation in migrating cells. J. Cell. Biol. 183 (2008) 401-408
20. Kleer C.G., van Golen K.L., Zhang Y., Wu Z.F., Rubin M.A., and Merajver S.D. Characterization of RhoC expression in benign and malignant breast disease. Am. J. Pathol. 160 (2002) 579-584
21. Hakem A., Sanchez-Sweatman O., You-Ten A., Duncan G., Wakeham A., Khokha R., and Mak T.W. RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis. Genes Dev. 19 (2005) 1974-1979
22. Ma L., Teruya-Feldstein J., and Weinberg R.A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449 (2007) 682-689
23. Sahai E., and Marshall C.J. ROCK and Dia have opposing effects on adherens junctions downstream of Rho. Nat. Cell Biol. 4 (2002) 408-415
24. O'Connor K.L., and Mercurio A.M. Protein kinase A regulates Rac and is required for the growth factor-stimulated migration of carcinoma cells. J. Biol. Chem. 276 (2001) 47895-47900
25. Baugher P.J., Krishnamoorthy L., Price J.E., and Dharmawardhane S.F. Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells. Breast Cancer. Res. 7 (2005) R965-R974
26. Han G., Fan B., Zhang Y., Zhou X., Wang Y., Dong H., Wei Y., Sun S., Hu M., Zhang J., and Wei L. Positive regulation of migration and invasion by vasodilator-stimulated phosphoprotein via Rac1 pathway in human breast cancer cells. Oncol. Rep. 20 (2008) 929-939
27. Chan A.Y., Coniglio S.J., Chuang Y.Y., Michaelson D., Knaus U.G., Philips M.R., and Symons M. Roles of the Rac1 and Rac3 GTPases in human tumor cell invasion. Oncogene 24 (2005) 7821-7829
28. Ostrander J.H., Daniel A.R., Lofgren K., Kleer C.G., and Lange C.A. Breast tumor kinase (Protein Tyrosine Kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells. Cancer Res. 67 (2007) 4199-4209
29. Bourguignon L.Y., Zhu H., Shao L., and Chen Y.W. Ankyrin-Tiam1 interaction promotes Rac1 signaling and metastatic breast tumor cell invasion and migration. J. Cell. Biol. 150 (2000) 177-191
30. Zuo Y., Shields S.K., and Chakraborty C. Enhanced intrinsic migration of aggressive breast cancer cells by inhibition of Rac1 GTPase. Biochem. Biophys. Res. Commun. 351 (2006) 361-367
31. Kim D., and Chung J. Akt: versatile mediator of cell survival and beyond. J. Biochem. Mol. Biol. 35 (2002) 106-115
32. Manning B.D., and Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 129 (2007) 1261-1274
33. Meili R., Ellsworth C., Lee S., Reddy T.B., Ma H., and Firtel R.A. Chemoattractant-mediated transient activation and membrane localization of Akt/PKB is required for efficient chemotaxis to cAMP in Dictyostelium. EMBO J. 18 (1999) 2092-2105
34. Kolsch V., Charest P.G., and Firtel R.A. The regulation of cell motility and chemotaxis by phospholipid signalling. J. Cell Sci. 121 (2007) 551-559
35. Enomoto A., Murakami H., Asai N., Morone N., Watanabe T., Kawai K., Murakumo Y., Usukura J., Kaibuchi K., and Takahashi M. Akt/PKB regulates actin organization and cell motility via Girdin/APE. Dev. Cell 9 (2005) 389-402
36. Kitamura T., Asai N., Enomoto A., Maeda K., Kato T., Ishida M., Jiang P., Watanabe T., Usukura J., Kondo T., Costantini F., Murohara T., and Takahashi M. Regulation of VEGF-mediated angiogenesis by the Akt/PKB substrate Girdin. Nat. Cell Biol. 10 (2008) 329-337
37. Ping J., Enomoto A., Jijiwa M., Kato T., Hasegawa T., Ishida M., Sato T., Asai N., Murakumo Y., and Takahashi M. An actin-binding protein Girdin regulates the motility of breast cancer cells. Cancer Res. 68 (2008) 1310-1318
38. Anai M., Shojima N., Katagiri H., Ogihara T., Sakoda H., Onishi Y., Ono H., Fujishiro M., Fukushima Y., Horike N., Viana A., Kikuchi M., Noguchi N., Takahashi S., Takata K., Oka Y., Uchijima Y., Kurihara H., and Asano T. A novel protein kinase B (PKB)/AKT-binding protein enhances PKB kinase activity and regulates DNA synthesis. J. Biol. Chem. 280 (2005) 18525-18535
39. Ghosh P., Garcia-Marcos M., Bornheimer S.J., and Farquhar M.G. Activation of Galphai3 triggers cell migration via regulation of GIV. J. Cell. Biol. 182 (2008) 381-393
40. Datta M.W., Macri E., Signoretti S., Renshaw A.A., and Loda M. Transition from in situ to invasive testicular germ cell neoplasia is associated with the loss of p21 and gain of mdm-2 expression. Mod. Pathol. 14 (2001) 437-442
41. Yang J.Y., Zong C.S., Xia W., Wei Y., Ali-Seyed M., Li Z., Broglio K., Berry D.A., and Hung M.C. MDM2 promotes cell motility and invasiveness by regulating E-cadherin degradation. Mol. Cell. Biol. 26 (2006) 7269-7282
42. Amiri A., Noei F., Jeganathan S., Kulkarni G., Pinke D.E., and Lee J.M. eEF1A2 activates Akt and stimulates Akt-dependent actin remodeling, invasion and migration. Oncogene 26 (2007) 3027-3040
43. Ju X., Katiyar S., Wang C., Liu M., Jiao X., Li S., Zhou J., Turner J., Lisanti M.P., Russell R.G., Mueller S.C., Ojeifo J., Chen W.S., Hay N., and Pestell R.G. Akt1 governs breast cancer progression in vivo. Proc. Natl. Acad. Sci. USA 104 (2007) 7438-7443
44. Irie H.Y., Pearline R.V., Grueneberg D., Hsia M., Ravichandran P., Kothari N., Natesan S., and Brugge J.S. Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J. Cell. Biol. 171 (2005) 1023-1034
45. Yoeli-Lerner M., Yiu G.K., Rabinovitz I., Erhardt P., Jauliac S., and Toker A. Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol. Cell 20 (2005) 539-550
46. Liu H., Radisky D.C., Nelson C.M., Zhang H., Fata J.E., Roth R.A., and Bissell M.J. Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2. Proc. Natl. Acad. Sci. USA 103 (2006) 4134-4139
47. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2 (2002) 442-454
48. Huber M.A., Kraut N., and Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr. Opin. Cell. Biol. 17 (2005) 548-558
49. Fuchs M., Hutzler P., Brunner I., Schlegel J., Mages J., Reuning U., Hapke S., Duyster J., Hirohashi S., Genda T., Sakamoto M., Uberall F., Höfler H., Becker K.F., and Luber B. Motility enhancement by tumor-derived mutant E-cadherin is sensitive to treatment with epidermal growth factor receptor and phosphatidylinositol 3-kinase inhibitors. Exp. Cell. Res. 276 (2002) 129-141
50. Hazan R.B., and Norton L. The epidermal growth factor receptor modulates the interaction of E-cadherin with the actin cytoskeleton. J. Biol. Chem. 273 (1998) 9078-9084
51. Yang Z., Rayala S., Nguyen D., Vadlamudi R.K., Chen S., and Kumar R. Pak1 phosphorylation of Snail, a master regulator of epithelial-to-mesenchyme transition, modulates Snail's subcellular localization and functions. Cancer Res. 65 (2005) 3179-3184
52. Laffin B., Wellberg E., Kwak H.I., Burghardt R.C., Metz R.P., Gustafson T., Schedin P., and Porter W.W. Loss of single minded-2s in the mouse mammary gland induces an epithelial-mesenchymal transition associated with up-regulation of Slug and matrix metalloprotease. Mol. Cell. Biol. 28 (2008) 1936-1946
53. Lo H.W., Hsu S.C., Xia W., Cao X., Shih J.Y., Wei Y., Abbruzzese J.L., Hortobagyi G.N., and Hung M.C. Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res. 67 (2007) 9066-9076
54. Min C., Eddy S.F., Sherr D.H., and Sonenshein G.E. NF-kappaB and epithelial to mesenchymal transition of cancer. J. Cell. Biochem. 104 (2008) 733-744
55. Huber M.A., Azoitei N., Baumann B., Grünert S., Sommer A., Pehamberger H., Kraut N., Beug H., and Wirth T. NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J. Clin. Invest. 114 (2004) 569-581
56. Zhou B.P., Deng J., Xia W., Xu J., Li Y.M., Gunduz M., and Hung M.C. Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat. Cell Biol. 6 (2004) 931-940
57. Bachelder R.E., Yoon S.-O., Franci C., de Herreros A.G., and Mercurio A.M. Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition. J. Cell Biol. 168 (2005) 29-33
58. Wells A. EGF receptor. Int. J. Biochem. Cell. Biol. 31 (1999) 637-643
59. Polo S., and Di Fiore P.P. Endocytosis conducts the cell signalling orchestra. Cell 124 (2006) 897-900
60. Sorkin A., and von Zastrow M. Signal transduction and endocytosis: close encounters of many kinds. Nat. Rev. Mol. Cell. Biol. 2 (2002) 600-614
61. Caswell P., and Norman J. Endocytic transport of integrins during cell migration and invasion. Trends Cell. Biol. 18 (2008) 257-263
62. Fujita Y., Krause G., Scheffner M., Zechner D., Leddy H.E., Behrens J., Sommer T., and Birchmeier W. Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat. Cell Biol. 4 (2002) 222-231
63. Kiosses W.B., Shattil S.J., Pampori N., and Schwartz M.A. Rac recruits high-affinity integrin αvβ3 to lamellipodia in endothelial cell migration. Nat. Cell Biol. 3 (2001) 316-320
64. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 110 (2002) 673-687
65. Guo W., and Giancotti F.G. Integrin signalling during tumour progression. Nat. Rev. Mol. Cell. Biol. 5 (2004) 816-826
66. Hollier B.G., Kricker J.A., Van Lonkhuyzen D.R., Leavesley D.I., and Upton Z. Substrate-bound insulin-like growth factor (IGF)-I-IGF binding protein-vitronectin-stimulated breast cell migration is enhanced by coactivation of the phosphatidylinositide 3-Kinase/AKT pathway by αv-integrins and the IGF-I receptor. Endocrinology 149 (2008) 1075-1090
67. Arboleda M.J., Lyons J.F., Kabbinavar F.F., Bray M.R., Snow B.E., Ayala R., Danino M., Karlan B.Y., and Slamon D.J. Overexpression of AKT2/protein kinase B beta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. Cancer Res. 63 (2003) 196-206
68. Li J., Ballif B.A., Powelka A.M., Dai J., Gygi S.P., and Hsu V.W. Phosphorylation of ACAP1 by Akt regulates the stimulation-dependent recycling of integrin beta1 to control cell migration. Dev. Cell 9 (2005) 663-673
69. Caswell P.T., and Norman J.C. Integrin trafficking and the control of cell migration. Traffic 7 (2006) 14-21
70. Simpson F., Martin S., Evans T.M., Kerr M., James D.E., Parton R.G., Teasdale R.D., and Wicking C. A novel hook-related protein family and the characterization of hook-related protein 1. Traffic 6 (2005) 442-458
71. Le-Niculescu H., Niesman I., Fischer T., DeVries L., and Farquhar M.G. Identification and characterization of GIV, a novel Galpha i/s-interacting protein found on COPI, endoplasmic reticulum-golgi transport vesicles. J. Biol. Chem. 280 (2005) 22012-22020
72. Williams T.M., Medina F., Badano I., Hazan R.B., Hutchinson J., Muller W.J., Chopra N.G., Scherer P.E., Pestell R.G., and Lisantia M.P. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. J. Biol. Chem. 279 (2004) 51630-51646
73. Sotgia F., Williams T.M., Schubert W., Medina F., Minetti C., Pestell R.G., and Lisanti M.P. Caveolin-1 deficiency (-/-) conveys premalignant alterations in mammary epithelia, with abnormal lumen formation, growth factor independence, and cell invasiveness. Am. J. Pathol. 168 (2006) 292-309
74. Fiucci G., Ravid D., Reich R., and Liscovitch M. Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells. Oncogene 21 (2002) 2365-2375
75. Liedtke C., Kersting C., Bürger H., Kiesel L., and Wülfing P. Caveolin-1 expression in benign and malignant lesions of the breast. World J. Surg. Oncol. 5 (2007) 110